New life for M&A derivatives

The surge in M&A deals this year has led to a sharp rise in the volume of deal-contingent swaps as firms look to protect themselves against naked exposures in the event of a failed bid. At the same time, a variety of new, large-scale exotic equity derivatives transactions has emerged

risk-1106-pg56-jpg

Historically, successive waves of mergers and acquisitions (M&A) activity were welcomed by investment banks for one reason: the advisory and capital markets business they stood to gain. During the most recent wave of M&A, banks have been able to pocket up to 100 basis points per deal in advisory fees and up to 200bp for work related to capital-raising ahead of acquisitions. Over the past year, however, derivatives business has begun to make up an increasingly important part of banks' M&A-related

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here